To stabilize this mutated form of CFTR, the authors used lumacaftor, a drug with affinity to ΔF508-CFTR used in CF, bound to the ligand EN523, a recruiter of the ubiquitin-specific deubiquitinase OTUB1. Here, CFTR is linked to cystic fibrosis.